Regulatory Update Post author:Sam Post published:January 20, 2017 Post category:Drug Industry Daily Source: Drug Industry Daily You Might Also Like DEA Proposes to Place Fentanyl Products in Schedule I January 1, 2018 Emergent’s Woes Continue as FDA Warning Letter Cites Poor Management Oversight August 16, 2022 FDA Issues Final Guidance on Physiologically-Based Pharmacokinetic Analyses September 4, 2018
